Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

Helen Y. Chu,Rupali Jain,Hu Xie,Paul S. Pottinger,David N. Fredricks

Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

2013

Helen Y. Chu
Rupali Jain
Hu Xie
Paul S. Pottinger
David N. Fredricks

Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear.

Keywords:

Hematopoietic stem cell transplantation
Voriconazole
Pathology
Therapeutic drug monitoring
Aspergillosis
Medical microbiology
Pulmonary aspergillosis
Medicine
Intensive care medicine
Retrospective cohort study
Adverse effect
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations